Cellulitis laboratory tests: Difference between revisions

Jump to navigation Jump to search
 
(28 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
{{Cellulitis}}
{{CMG}}; {{AE}} [[User:Aditya Govindavarjhulla|Aditya Govindavarjhulla, M.B.B.S.]]


{{Cellulitis}}
{{CMG}}, '''Associate Editor(s)-In-Chief:''' [[User:Aditya Govindavarjhulla|Aditya Govindavarjhulla, M.B.B.S.]]
==Overview==
==Overview==
With changing trends in medicine, recommended lab investigations are changing. Blood cultures and blood counts are the mainstay for the treatment and prognosis. Other blood tests like ESR and CRP help in prognosis.Levels of ESR and CRP at admission may predict the severity and duration of hospitalization.<ref name="pmid16321649">{{cite journal| author=Lazzarini L, Conti E, Tositti G, de Lalla F| title=Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. | journal=J Infect | year= 2005 | volume= 51 | issue= 5 | pages= 383-9 | pmid=16321649 | doi=10.1016/j.jinf.2004.12.010 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16321649  }} </ref>


==Lab Work Up==
When cellulitis is accompanied by signs and symptoms of systemic toxicity (e.g., [[fever]] or [[hypothermia]], [[tachycardia]], and [[hypotension]]), blood samples should be collected for culture with susceptibility tests, [[complete blood cell count]] with differential, [[creatinine]], [[bicarbonate]], [[creatine phosphokinase]], and [[C-reactive protein]] levels. A definitive etiologic diagnosis by means of needle aspiration or punch biopsy may be considered in the presence of elevated serum [[creatinine]], decreased serum [[bicarbonate]], elevated [[creatine phosphokinase]], marked left shift, or [[CRP|C-reactive protein]] &gt;13 mg/L.<ref name="Stevens-2005">{{Cite journal  | last1 = Stevens | first1 = DL. | last2 = Bisno | first2 = AL. | last3 = Chambers | first3 = HF. | last4 = Everett | first4 = ED. | last5 = Dellinger | first5 = P. | last6 = Goldstein | first6 = EJ. | last7 = Gorbach | first7 = SL. | last8 = Hirschmann | first8 = JV. | last9 = Kaplan | first9 = EL. | title = Practice guidelines for the diagnosis and management of skin and soft-tissue infections. | journal = Clin Infect Dis | volume = 41 | issue = 10 | pages = 1373-406 | month = Nov | year = 2005 | doi = 10.1086/497143 | PMID = 16231249 }}</ref>


==Laboratory Findings==


* Cultures can be taken from Wounds, Pus &  Blood. Blood cultures are positive only in few cases of mild infection/ community acquired cellulitis.<ref name="pmid10585800">{{cite journal| author=Perl B, Gottehrer NP, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM| title=Cost-effectiveness of blood cultures for adult patients with cellulitis. | journal=Clin Infect Dis | year= 1999 | volume= 29 | issue= 6 | pages= 1483-8 | pmid=10585800 | doi=10.1086/313525 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10585800  }} </ref> Blood cultures are significant when systemic spread occurs.
'''Blood tests'''
* In cases of abscess, gram staining and cultures of drained fluid may be helpful in further management of the condition.


*Total blood count increases. Leukocytosis is seen is most of the cases but in few toxin mediated cellulitis leucopenia may be observed.
*Total blood count increases. [[Leukocytosis]] is seen in most of the cellulitis cases, but in a few toxin mediated cellulitis cases [[leucopenia]] may be observed.
*ESR and CRP can be used as prognostic indicators.New recommendations are more favorable towards the use of CRP compared to ESR.<ref>http://dermatology.jwatch.org/cgi/content/full/2011/318/1</ref>
*[[ESR]] and [[CRP]] can be used as prognostic indicators. New recommendations are more favorable towards the use of [[CRP]] compared to [[ESR]] as an indicator of infection severity.<ref>http://dermatology.jwatch.org/cgi/content/full/2011/318/1</ref> Elevated ESR and CRP levels on admission are associated with a longer hospitalization period.<ref name="pmid16321649">{{cite journal| author=Lazzarini L, Conti E, Tositti G, de Lalla F| title=Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. | journal=J Infect | year= 2005 | volume= 51 | issue= 5 | pages= 383-9 | pmid=16321649 | doi=10.1016/j.jinf.2004.12.010 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16321649  }} </ref>
*If repeated infections of cellulitis are occurring [[Diabetes]] should be ruled out. Fasting blood sugars will help in this.
*If repeated infections of cellulitis occur, [[diabetes]] should be ruled out as a cause. Blood glucose levels will assist in determining if diabetes has had any influence on the development of cellulitis.


;Imaging may be considered when
'''Staining and cultures'''
*Bone involvement in suspected.
*Foreign body in-situ is one of the differential.
Depending on the site involved imaging may be required. In cases of orbital cellulits ct scan is needed to differentiate between pre/post septal cellulitis.


Microbial resistance to drugs is a very common and serious problem.<ref>http://www.nejm.org/doi/full/10.1056/nejmoa043252</ref> In cases of non resolution, severe infections leading to hospitalization drug sensitivity has to be tested.
*[[Blood culture|Blood cultures]] are warranted in the following conditions:<ref name="Stevens-2005">{{Cite journal  | last1 = Stevens | first1 = DL. | last2 = Bisno | first2 = AL. | last3 = Chambers | first3 = HF. | last4 = Everett | first4 = ED. | last5 = Dellinger | first5 = P. | last6 = Goldstein | first6 = EJ. | last7 = Gorbach | first7 = SL. | last8 = Hirschmann | first8 = JV. | last9 = Kaplan | first9 = EL. | title = Practice guidelines for the diagnosis and management of skin and soft-tissue infections. | journal = Clin Infect Dis | volume = 41 | issue = 10 | pages = 1373-406 | month = Nov | year = 2005 | doi = 10.1086/497143 | PMID = 16231249 }}</ref><ref name="Swartz-2004">{{Cite journal  | last1 = Swartz | first1 = MN. | title = Clinical practice. Cellulitis. | journal = N Engl J Med | volume = 350 | issue = 9 | pages = 904-12 | month = Feb | year = 2004 | doi = 10.1056/NEJMcp031807 | PMID = 14985488 }}</ref>
 
:*Accompanying signs and symptoms suggestive of [[bacteremia]] (e.g., [[fever|high fever]], [[chills]], [[hypothermia]], [[tachycardia]], and [[hypotension]])
:*Buccal cellulitis
:*[[Periorbital cellulitis]]
:*Cellulitis superimposed on [[lymphedema]]
:*When a salt-water or fresh-water source of infection is likely
 
*Blood cultures are positive only in few cases of mild infection and community acquired cellulitis. <ref name="pmid10585800">{{cite journal| author=Perl B, Gottehrer NP, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM| title=Cost-effectiveness of blood cultures for adult patients with cellulitis. | journal=Clin Infect Dis | year= 1999 | volume= 29 | issue= 6 | pages= 1483-8 | pmid=10585800 | doi=10.1086/313525 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10585800  }} </ref> Blood cultures become a significant diagnostic tool when the inflammation present in cellulitis spreads systemically.
*In cases where an [[abscess]] has formed, gram staining and cultures of the drained fluid may be helpful in further management of the condition.
*In cases of recurring cellulitis of the foot, fungal infections have to be ruled out.  Skin scrapings will be helpful for the diagnosis.
 
'''Drug Resistance'''
 
*Microbial resistance to drugs is a very common and serious problem.<ref>http://www.nejm.org/doi/full/10.1056/nejmoa043252</ref> In cases of non resolution, severe infections leading to hospitalization drug sensitivity has to be tested.
 
==Gallery==
 
<gallery>
File:Ellulitis02.jpeg| Gram-negative Haemophilus influenzae bacteria, which were cultured on chocolate agar medium (10x mag). <SMALL><SMALL>''[http://phil.cdc.gov/phil/home.asp From Public Health Image Library (PHIL).] ''<ref name="PHIL"> {{Cite web | title = Public Health Image Library (PHIL) | url = http://phil.cdc.gov/phil/home.asp}}</ref></SMALL></SMALL>
</gallery>


==References==
==References==
Line 26: Line 43:


[[Category:Disease]]
[[Category:Disease]]
[[Category:Infectious disease]]
 
[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
Line 32: Line 49:
[[Category:Diseases involving the fasciae]]
[[Category:Diseases involving the fasciae]]
[[Category:Inflammations]]
[[Category:Inflammations]]
[[Category:Overview complete]]
{{WH}}
{{WS}}

Latest revision as of 16:14, 13 January 2021

Cellulitis Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Cellulitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cellulitis laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cellulitis laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cellulitis laboratory tests

CDC on Cellulitis laboratory tests

Cellulitis laboratory tests in the news

Blogs on Cellulitis laboratory tests

Directions to Hospitals Treating Cellulitis

Risk calculators and risk factors for Cellulitis laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S.

Overview

When cellulitis is accompanied by signs and symptoms of systemic toxicity (e.g., fever or hypothermia, tachycardia, and hypotension), blood samples should be collected for culture with susceptibility tests, complete blood cell count with differential, creatinine, bicarbonate, creatine phosphokinase, and C-reactive protein levels. A definitive etiologic diagnosis by means of needle aspiration or punch biopsy may be considered in the presence of elevated serum creatinine, decreased serum bicarbonate, elevated creatine phosphokinase, marked left shift, or C-reactive protein >13 mg/L.[1]

Laboratory Findings

Blood tests

  • Total blood count increases. Leukocytosis is seen in most of the cellulitis cases, but in a few toxin mediated cellulitis cases leucopenia may be observed.
  • ESR and CRP can be used as prognostic indicators. New recommendations are more favorable towards the use of CRP compared to ESR as an indicator of infection severity.[2] Elevated ESR and CRP levels on admission are associated with a longer hospitalization period.[3]
  • If repeated infections of cellulitis occur, diabetes should be ruled out as a cause. Blood glucose levels will assist in determining if diabetes has had any influence on the development of cellulitis.

Staining and cultures

  • Blood cultures are positive only in few cases of mild infection and community acquired cellulitis. [5] Blood cultures become a significant diagnostic tool when the inflammation present in cellulitis spreads systemically.
  • In cases where an abscess has formed, gram staining and cultures of the drained fluid may be helpful in further management of the condition.
  • In cases of recurring cellulitis of the foot, fungal infections have to be ruled out. Skin scrapings will be helpful for the diagnosis.

Drug Resistance

  • Microbial resistance to drugs is a very common and serious problem.[6] In cases of non resolution, severe infections leading to hospitalization drug sensitivity has to be tested.

Gallery

References

  1. 1.0 1.1 Stevens, DL.; Bisno, AL.; Chambers, HF.; Everett, ED.; Dellinger, P.; Goldstein, EJ.; Gorbach, SL.; Hirschmann, JV.; Kaplan, EL. (2005). "Practice guidelines for the diagnosis and management of skin and soft-tissue infections". Clin Infect Dis. 41 (10): 1373–406. doi:10.1086/497143. PMID 16231249. Unknown parameter |month= ignored (help)
  2. http://dermatology.jwatch.org/cgi/content/full/2011/318/1
  3. Lazzarini L, Conti E, Tositti G, de Lalla F (2005). "Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital". J Infect. 51 (5): 383–9. doi:10.1016/j.jinf.2004.12.010. PMID 16321649.
  4. Swartz, MN. (2004). "Clinical practice. Cellulitis". N Engl J Med. 350 (9): 904–12. doi:10.1056/NEJMcp031807. PMID 14985488. Unknown parameter |month= ignored (help)
  5. Perl B, Gottehrer NP, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM (1999). "Cost-effectiveness of blood cultures for adult patients with cellulitis". Clin Infect Dis. 29 (6): 1483–8. doi:10.1086/313525. PMID 10585800.
  6. http://www.nejm.org/doi/full/10.1056/nejmoa043252
  7. "Public Health Image Library (PHIL)".